Pyrotinib trials for Advanced Breast Cancer

All Pyrotinib trials · All Advanced Breast Cancer trials

Phase breakdown

Recruiting trials studying Pyrotinib for Advanced Breast Cancer

• Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer
  NCT07180082 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
  NCT07600164 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
  NCT06217185 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: Female · 1 location

Common questions

How many trials study Pyrotinib for Advanced Breast Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.